Mark Jason Heath Ellison, Chief Development Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 1,806 shares at $20.20 ($36K) on 2023-01-05, disclosed to the SEC on 2023-01-05.
Seasonal sale ($36k) by Chief Development Officer — this insider has traded OPNT in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |